TCR2 Therapeutics, Inc. (NASDAQ:TCRR)

About the company

TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering t-cells for cancer therapy. The firm offers cancer therapy, t-cell biology, immunology and molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of t-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle in May 2015 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

83

CEO

Garry E. Menzel

Exchange

NASDAQ

Website

http://www.tcr2.com

$NoneM

Total Revenue

83

Employees

$383.04M

Market Capitalization

-38.00

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 381124.48 82729.00 6.12 22.21 20.75
Merck & Co., Inc. MRK 196786.55 48081.00 7.39 19.42 21.10
Pfizer Inc. PFE 190835.04 50660.00 2.89 12.08 31.17
Eli Lilly & Co. LLY 151075.27 23087.00 51.27 26.63 23.97
AbbVie, Inc. ABBV 143695.72 34057.00 -23.00 17.14 24.65
Bristol Myers Squibb Co. BMY 108491.37 31006.00 2.63 92.24 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4839.72 20.00 22.93 -15.57 -150.30
Nektar Therapeutics NKTR 4229.28 137.00 3.30 -9.21 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3855.28 1.00 35.64 -5.90 None
Allakos, Inc. ALLK 3213.86 None 6.98 -34.36 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
Karuna Therapeutics, Inc. KRTX 2485.08 None 6.49 -61.27 None
OPKO Health, Inc. OPK 2448.18 891.00 1.74 -8.37 -32.92
Turning Point Therapeutics, Inc. TPTX 2195.28 None 6.61 -18.37 None
IGM Biosciences, Inc. IGMS 2191.70 None 9.66 -40.40 None
Apellis Pharmaceuticals, Inc. APLS 2141.70 None 9.46 -5.13 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Principia Biopharma, Inc. PRNB 1792.84 30.00 6.38 -25.51 -242.01
Springworks Therapeutics, Inc. SWTX 1695.06 None 5.51 -27.19 None
Y-mAbs Therapeutics, Inc. YMAB 1495.17 None 9.16 -16.23 None
Zymeworks, Inc. ZYME 1393.98 26.00 2.89 -8.22 -629.37
Tricida, Inc. TCDA 1300.46 None 6.69 -6.16 None
Akcea Therapeutics, Inc. AKCA 1289.13 341.00 2.65 -45.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1267.20 None 6.56 -10.47 None
Akero Therapeutics, Inc. AKRO 1138.62 None 9.51 -22.44 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Arcutis Biotherapeutics, Inc. ARQT 1076.33 None 4.59 -17.21 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 971.88 123.00 5.96 -9.03 -87.86
Constellation Pharmaceuticals, Inc. CNST 932.16 None 4.39 -10.04 None
G1 Therapeutics, Inc. GTHX 811.30 1.00 3.51 -6.19 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 750.75 None 4.17 -2.76 None
Quanterix Corp. QTRX 742.50 60.00 6.55 -16.98 -71.52
Krystal Biotech, Inc. KRYS 695.98 None 4.06 -33.56 None
Oric Pharmaceuticals, Inc. ORIC 691.88 None -7.51 -22.88 None
Applied Therapeutics, Inc. APLT 670.34 14.00 4.33 -13.60 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Aprea Therapeutics, Inc. APRE 647.22 None 5.73 -19.14 None
Amneal Pharmaceuticals, Inc. AMRX 637.05 1679.00 4.39 -2.92 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 632.06 19.00 58.58 -22.72 -151.34
Keros Therapeutics, Inc. KROS 601.74 8.00 -27.18 -28.33 -285.35
Oyster Point Pharma, Inc. OYST 546.00 None 5.49 -9.49 None
Mirum Pharmaceuticals, Inc. MIRM 491.75 None 3.20 -7.26 None
SIGA Technologies, Inc. SIGA 467.40 19.00 5.23 -23.75 -94.00
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Fulcrum Therapeutics, Inc. FULC 444.13 1.00 7.48 -6.44 None
Osmotica Pharmaceuticals Plc OSMT 442.80 232.00 3.36 -1.61 -115.44
Biospecifics Technologies Corp. BSTC 442.54 40.00 3.59 18.93 61.80
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 395.33 None 3.82 -11.23 None
DURECT Corp. DRRX 390.60 28.00 30.00 -16.15 -82.94
TCR2 Therapeutics, Inc. TCRR 383.04 None 2.62 -38.00 None
Relmada Therapeutics, Inc. RLMD 380.97 0.00 5.68 -31.83 -877.66
Crinetics Pharmaceuticals, Inc. CRNX 376.08 1.00 4.75 -6.45 -447.78
Kala Pharmaceuticals, Inc. KALA 365.76 6.00 4.00 -3.98 None
Ocular Therapeutix, Inc. OCUL 356.16 6.00 -43.65 -3.88 None
Ovid Therapeutics, Inc. OVID 336.15 None 7.95 -5.15 None
Aeglea Biotherapeutics, Inc. AGLE 292.05 4.00 9.22 -3.64 -523.27
Urovant Sciences Ltd. UROV 285.60 None -5.06 -1.98 None
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
IDEAYA Biosciences, Inc. IDYA 266.80 None 4.05 -6.12 None
Gritstone Oncology, Inc. GRTS 255.60 4.00 2.29 -2.45 None
Spero Therapeutics, Inc. SPRO 247.38 12.00 3.26 -3.04 -656.72
AMAG Pharmaceuticals, Inc. AMAG 240.04 321.00 0.92 -0.65 -115.05
KalVista Pharmaceuticals, Inc. KALV 221.58 12.00 2.45 -6.84 -263.38
Verrica Pharmaceuticals, Inc. VRCA 219.00 None 4.00 -7.18 None
Lannett Co., Inc. LCI 218.12 542.00 0.75 -7.17 -5.77
Kaleido Biosciences, Inc. KLDO 202.80 None 7.19 -2.77 None
Sutro Biopharma, Inc. STRO 200.79 41.00 3.81 -3.29 -148.06
Veru, Inc. VERU 198.90 39.00 6.65 -20.40 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 177.79 1.00 5.37 -4.18 None
Protara Therapeutics, Inc. TARA 173.10 None 2.60 -11.23 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Lyra Therapeutics, Inc. LYRA 145.68 1.00 -1.24 -8.73 -491.16
Cyclerion Therapeutics, Inc. CYCN 145.26 6.00 1.83 -1.40 None
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
scPharmaceuticals, Inc. SCPH 143.36 119.00 3.66 -4.57 -27.05
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Evelo Biosciences, Inc. EVLO 134.40 None 4.94 -1.53 None
Harrow Health, Inc. HROW 130.26 51.00 8.35 -5.27 -47.54
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
Aquestive Therapeutics, Inc. AQST 123.48 49.00 -7.11 -1.76 -139.64
TFF Pharmaceuticals, Inc. TFFP 122.36 None 4.74 -3.16 None
Ayala Pharmaceuticals, Inc. AYLA 120.00 3.00 -2.82 -5.81 -679.19
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Trevi Therapeutics, Inc. TRVI 104.76 None 2.22 -3.57 None
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Milestone Pharmaceuticals, Inc. MIST 91.50 None 0.90 -1.47 None
Eton Pharmaceuticals, Inc. ETON 90.90 1.00 9.90 -4.55 None
EyePoint Pharmaceuticals, Inc. EYPT 81.75 26.00 5.77 -1.67 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 72.57 6.00 9.32 -4.12 -293.61
Xeris Pharmaceuticals, Inc. XERS 72.24 4.00 3.58 -0.56 None
Navidea Biopharmaceuticals, Inc. NAVB 68.85 1.00 -50.63 -6.23 -65.13
Baudax Bio, Inc. BXRX 63.54 None -1.73 -0.91 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
BiomX, Inc. PHGE 58.74 None 1.55 -1.37 None
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 54.12 20.00 1.63 -2.87 -51.58
Menlo Therapeutics, Inc. MNLO 48.72 2.00 4.10 -0.52 -483.51
Eyenovia, Inc. EYEN 45.12 None 4.55 -2.20 None
Edesa Biotech, Inc. EDSA 44.01 0.00 6.27 -0.46 -395.23
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.48 None 3.52 -4.40 None
Acer Therapeutics, Inc. ACER 36.30 3.00 2.65 -1.39 -274.69
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
AgeX Therapeutics, Inc. AGE 34.88 2.00 -45.90 -2.87 -658.11
Citius Pharmaceuticals, Inc. CTXR 34.83 None 2.58 -2.02 None
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Allena Pharmaceuticals, Inc. ALNA 33.35 None 4.39 -0.77 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
CNS Pharmaceuticals, Inc. CNSP 29.28 None 5.08 -5.38 None
Millendo Therapeutics, Inc. MLND 25.95 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 19.76 1.00 8.67 -1.18 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 14.80 None 3.61 -1.95 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.38 5.00 -3.31 -0.46 -602.34
PDS Biotechnology Corp. PDSB 13.93 None 1.54 -0.55 None
Titan Pharmaceuticals, Inc. TTNP 11.60 4.00 4.83 -0.64 -437.91
Novus Therapeutics, Inc. NVUS 7.74 None 0.66 -0.37 None
Brickell Biotech, Inc. BBI 4.66 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

TCR2 Therapeutics Inc.

4d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Tcr2 Therapeutics (NASDAQ:TCRR) Downgraded to “Hold” at ValuEngine

6d ago, source: modernreaders.com

Tcr2 Therapeutics (NASDAQ:TCRR) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Thursday, ValuEngine reports. Other research ...

Hedge Funds Have Never Been This Bullish On TCR2 Therapeutics Inc. (TCRR)

26d ago, source: YAHOO!

In this article, we will take a closer look at hedge fund sentiment towards TCR2 Therapeutics Inc. (NASDAQ:TCRR). TCR2 Therapeutics Inc. (NASDAQ:TCRR) investors should be aware of an increase in ...

TCR² Therapeutics to Present at the BMO Prescriptions for Success Healthcare Conference

23d ago, source: GlobeNewswire

June 17, 2020 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical ... page of the Company’s website at www.investors.tcr2.com. An archived replay will be available for at ...

Artiva lands $78M financing series to back NK cell therapies pipeline

14d ago, source: BioWorld

Tom Farrell, president and CEO, Artiva Farrell spent 11 years building Bellicum Pharmaceuticals Inc., while Flynn had spent seven years leading early program development at Fate Therapeutics Inc. When ...

Hedge Funds Have Never Been This Bullish On TCR2 Therapeutics Inc. (TCRR)

26d ago, source: Insider Monkey

In this article, we will take a closer look at hedge fund sentiment towards TCR2 Therapeutics Inc. (NASDAQ:TCRR). Video: Watch our video about the top 5 most popular hedge fund stocks. Hedge funds ...

TCR² Therapeutics to Present at the BMO Prescriptions for Success Healthcare Conference

23d ago, source: Business Insider

© 2020 Insider Inc. and finanzen.net GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.